Abstract:High-mobility group box 1 protein (HMGB1) is a chromatin protein and acts as a cytokine involved in inflammation, cell proliferation, differentiation, migration and stem cell recruitment. So far, little is known about its effect on hematopoietic stem cells (HSCs). In this study, we investigated whether receptors for HMGB1 are expressed on human CD34+ HSCs, and whether HMGB1 could affect HSCs proliferation, differentiation and migration in vitro. As examined by FACS analysis and RT-PCR, cord blood CD34+ HSCs express the HMGB1 receptors RAGE (receptor for advanced glycation end products), TLR2 (Toll-like receptor 2) and TLR4. To study the effects of HMGB1 on CD34+ HSCs proliferation and differentiation, freshly isolated cord blood CD34+ HSCs were cultured for 7 days in medium alone or in the presence of HMGB1. Flow cytometric analysis showed that HMGB1 (50ng/ml) can induce the differentiation of CD34+ HSCs along the granulo-monocytic (CD14+, CD13+) lineage and erythropoiesis (CD71+). In contrast, HMGB1 did not induce the expression of CD41, a marker for megakaryocyte lineage. The numbers of cells cultured in the presence of HMGB1 were always increased in comparison with controls. Furthermore, higher numbers of granulomonocytic progenitors (CFU-GM), erythroid progenitors (BFU-E), and CFU-MIX were confirmed by CFC assays in a HMGB1 dose dependent manner after 14-day culture. The results suggest that HMGB1 enhances CD34+ HSCs proliferation and differentiation. We next assessed the effects of HMGB1 on HSCs migration by chemotaxis assay using Boyden chambers. HMGB1 dose-dependently increased the chemotactic migration of CD34+ HSCs. A neutralizing anti-RAGE antibody significantly blocked the HMGB1-induced migration of HSCs, whereas neutralizing TLR2 and TLR4 antibodies did not significantly influence HMGB1-stimulated HSCs migration, suggesting that the migratory effect of HMGB1 on human HSCs is predominantly mediated by RAGE. In summary, our results provide the first report of HMGB1 receptors expression profile of human cord blood CD34+ HSCs and demonstrate that HMGB1 can increase the proliferation and migration of HSCs and directly induce of HSCs along myeloid differentiation and erythropoiesis in vitro. Further studies will be needed to clarify the mechanism of HMGB1 activation and the physiological function of HMGB1 in HSCs in vivo.

HMGB1 Can Activate Cartilage Progenitor Cells in Response to Cartilage Injury Through the CXCL12/CXCR4 Pathway.

Spatial and Temporal Expression Pattern of Hmgb2 in Rabbit Condylar Cartilage Following Anterior Disc Displacement

HMGB1 promotes cellular chemokine synthesis and potentiates mesenchymal stromal cell migration via Rap1 activation.

Migrating Progenitor Cells Derived From Injured Cartilage Surface Respond to Damage-Associated Molecular Patterns

Dual Regulatory Roles of HMGB1 in Inflammatory Reaction of Chondrocyte Cells and Mice.

Signaling Pathways Involved In The Effects Of Hmgb1 On Mesenchymal Stem Cell Migration And Osteoblastic Differentiation

Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage

High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury

Hmgb1 Promotes the Secretion of Multiple Cytokines and Potentiates the Osteogenic Differentiation of Mesenchymal Stem Cells Through the Ras/Mapk Signaling Pathway

Extracellular HMGB-1 Activates Inflammatory Signaling in Tendon Cells and Tissues.

HMGB2 promotes chondrocyte proliferation under negative pressure through the phosphorylation of AKT

Kartogenin mediates cartilage regeneration by stimulating the IL-6/Stat3-dependent proliferation of cartilage stem/progenitor cells

Role of Integrin ß1 and Tenascin C Mediate TGF-SMAD2/3 Signaling in Chondrogenic Differentiation of BMSCs Induced by Type I Collagen Hydrogel

Endogenus chondrocytes immobilized by G-CSF in nanoporous gels enable repair of critical-size osteochondral defects

Overexpression of HMGB1 A-box Reduced IL-1β-induced MMP Expression and the Production of Inflammatory Mediators in Human Chondrocytes.

High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway.

Human Cartilage‐Derived Progenitors Resist Terminal Differentiation and Require CXCR4 Activation to Successfully Bridge Meniscus Tissue Tears

Crucial role of the terminal complement complex in chondrocyte death and hypertrophy after cartilage trauma

Extracellular HMGB1 Enhances Proliferation, Differentiation and Migration of Human CD34+ Hematopoietic Stem Cells in Vitro

High Mobility Group Box 1 Activates Toll Like Receptor 4 Signaling in Hepatic Stellate Cells

High mobility group box chromosomal protein 1 promotes matrix metalloproteinase-13 production in synovial fibroblasts